Position statement on the management of cardiac electrophysiology and cardiac implantable electronic devices in Australia during the COVID-19 pandemic: a living document

Kumar, S.Haqqani, H.Wynn, G.Pathak, R.K.Lipton, J.Mahajan, R.Sanders, P.Healey, S.Wilsmore, B.Mariani, J.A.Thomas, S.P.Weerasooriya, R.McGavigan, A.Gould, P.A.Weatherley, P.Saad, N.Cowan, M.Turnbull, S.Trivic, I.Wong, M.et al.2020-07-212020-07-212020Heart Lung and Circulation, 2020; 29(6):e57-e681443-95061444-2892http://hdl.handle.net/2440/126643The COVID-19 pandemic poses a significant stress on health resources in Australia. The Heart Rhythm Council of the Cardiac Society of Australia and New Zealand aims to provide a framework for efficient resource utilisation balanced with competing risks when appropriately treating patients with cardiac arrhythmias. This document provides practical recommendations for the electrophysiology (EP) and cardiac implantable electronic devices (CIED) services in Australia. The document will be updated regularly as new evidence and knowledge is gained with time.en© 2020 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australiaand New Zealand (CSANZ)COVID-19cardiac electrophysiologycardiac implantable electronic devicescongenital heart diseasepersonal protective equipmentPosition statement on the management of cardiac electrophysiology and cardiac implantable electronic devices in Australia during the COVID-19 pandemic: a living documentJournal article100002153210.1016/j.hlc.2020.04.0010005451107000012-s2.0-85084176970533628Pathak, R.K. [0000-0002-7391-6867]Mahajan, R. [0000-0003-3375-5568]Sanders, P. [0000-0003-3803-8429]